Presented by: Dr. Mashfiqul HasanPresented by: Dr. Mashfiqul Hasan
EmOC (anaesthesia) traineeEmOC (anaesthesia) trainee
ICMHICMH
Shock is a state of wide spread tissueShock is a state of wide spread tissue
hypo perfusion caused byhypo perfusion caused by
an inadequate cardiac output oran inadequate cardiac output or
ineffective circulatory blood volume,ineffective circulatory blood volume,
leading to inadequate supply of oxygenleading to inadequate supply of oxygen
and nutrients to the tissues and removal ofand nutrients to the tissues and removal of
metabolic wastes from there to the organsmetabolic wastes from there to the organs
of excretion.of excretion.
What isWhat is shock ?shock ?What isWhat is shock ?shock ?
Shock caused by inadequate cardiacShock caused by inadequate cardiac
outputoutput
CO = SV x HRCO = SV x HR
Stroke
Volum
e
Stroke VolumeStroke Volume
Volume of Blood pumped by eachVolume of Blood pumped by each
ventricle during 1 cardiac cycle.ventricle during 1 cardiac cycle.
What affects Stroke volume?
Heart
Muscle
Damag
e
Blood
Volume
Mechanica
lObstructi
on
Mechanic
al
Rhythm
Problems
Heart rateHeart rate
Sever bradycardia due to any cause.Sever bradycardia due to any cause.
Shock due to ineffective circulatoryShock due to ineffective circulatory
blood volumeblood volume
BP = CO x SVRBP = CO x SVR
Stages of shockStages of shock
Non progressive stageNon progressive stage
Progressive stageProgressive stage
Irreversible stageIrreversible stage
Classification of shockClassification of shock
Hypovolemic shockHypovolemic shock
Cardiogenic shockCardiogenic shock
Distributive shockDistributive shock
Obstructive shockObstructive shock
Hypovolemic shockHypovolemic shock
 Loss of blood:Loss of blood:
 External hemorrhage: trauma(accidental, surgical), GIExternal hemorrhage: trauma(accidental, surgical), GI
bleeding, PV bleedingbleeding, PV bleeding
 Internal hemorrhage: hemothorax, hemoperitoneum,Internal hemorrhage: hemothorax, hemoperitoneum,
hematoma, haemorrhage due to pelvic bone fracture,hematoma, haemorrhage due to pelvic bone fracture,
femur fracture, etc.femur fracture, etc.
 Loss of plasma: burn, exfoliative dermatitisLoss of plasma: burn, exfoliative dermatitis
 Loss of fluid & electrolytes:Loss of fluid & electrolytes:
 External: diarrhoea, vomiting, excessive sweating,External: diarrhoea, vomiting, excessive sweating,
hyperosmolar state (DKA, HONKDC)hyperosmolar state (DKA, HONKDC)
 Internal: pancreatitis, ascites, bowel obstructionInternal: pancreatitis, ascites, bowel obstruction
Effect of hemorrhage on cardiacEffect of hemorrhage on cardiac
output & blood pressureoutput & blood pressure
100%100%
50%50%
00 1010 2020 3030 4040 5050
ArterialArterial pressurepressure
Cardiac outputCardiac output
Percentage of total blood removedPercentage of total blood removed
What prevented fall of bloodWhat prevented fall of blood
pressure?pressure?
 Reflex sympathetic compensation:Reflex sympathetic compensation:
 Arterioles constrict, increasing peripheral resistanceArterioles constrict, increasing peripheral resistance
 Vein & venous reservoirs constrict (esp. skin &Vein & venous reservoirs constrict (esp. skin &
splanchnic), thereby increasing the venous returnsplanchnic), thereby increasing the venous return
 Stimulation of the cardiac activityStimulation of the cardiac activity
 Activation of Renin-Angiotensin-AldosteroneActivation of Renin-Angiotensin-Aldosterone
systemsystem
 Formation and release of vasopressinFormation and release of vasopressin
Decreased cardiac outputDecreased cardiac output
Decreased arterial pressureDecreased arterial pressure
Decreased systemic blood flowDecreased systemic blood flow
Decreased nutrition of tissuesDecreased nutrition of tissues Intravascular clottingIntravascular clottingDecreased cardiac nutritionDecreased cardiac nutrition
Decreased nutritionDecreased nutrition
of vascular systemof vascular system
Decreased nutritionDecreased nutrition
of the brainof the brain
Tissue ischemiaTissue ischemia
Decreased vasomotorDecreased vasomotor
activityactivity
Vascular dilatationVascular dilatation
Venous poolingVenous pooling
Of bloodOf blood
Cardiac depressionCardiac depression Decreased venous returnDecreased venous return
IncreasedIncreased
CapillaryCapillary
permeabilitypermeability
DecreasedDecreased
blood volumeblood volume
Release ofRelease of
Toxins/lactic acidosisToxins/lactic acidosis
Progression of shockProgression of shock
Progressive shockProgressive shock
Classification of HaemorrhageClassification of Haemorrhage
 Class-I: Blood loss 15%Class-I: Blood loss 15%
 Normal pulse rate and blood pressureNormal pulse rate and blood pressure
 Tilt test +Tilt test +
 Class-II: Blood loss 20-25%Class-II: Blood loss 20-25%
 Tachycardia, TachypnoeaTachycardia, Tachypnoea
 Low systolic blood pressureLow systolic blood pressure
 Pulse pressure less than 30mmHgPulse pressure less than 30mmHg
 Delayed capillary fillingDelayed capillary filling
 Class-III: Blood loss 30-35%Class-III: Blood loss 30-35%
 Skin-cold, clammy and paleSkin-cold, clammy and pale
 Severe drop in blood pressureSevere drop in blood pressure
 Restlessness, oliguria, metabolic acidosisRestlessness, oliguria, metabolic acidosis
 Class-IV Blood loss 40-50%Class-IV Blood loss 40-50%
 Profound hypotensionProfound hypotension
 Carotid pulse may only be palpableCarotid pulse may only be palpable
 Irreversible shockIrreversible shock
DiagnosisDiagnosis
HistoryHistory
Physical signs of haemodynamic instabilityPhysical signs of haemodynamic instability
The diagnosis is more difficult when theThe diagnosis is more difficult when the
source of blood loss is occult, as into thesource of blood loss is occult, as into the
gastrointestinal tract, fracture of femur,gastrointestinal tract, fracture of femur,
pelvic fracture or when plasma volumepelvic fracture or when plasma volume
alone is depleted.alone is depleted.
MonitoringMonitoring
 Patients in shock require care in an intensivePatients in shock require care in an intensive
care unit.care unit.
 Arterial pressure through an indwelling line,Arterial pressure through an indwelling line,
pulse, and respiratory rate should be monitoredpulse, and respiratory rate should be monitored
continuously;continuously;
 A Foley catheter should be inserted to followA Foley catheter should be inserted to follow
urine flow;urine flow;
 Mental status should be assessed frequently.Mental status should be assessed frequently.
 Invasive monitoring: Pulmonary artery catheterInvasive monitoring: Pulmonary artery catheter
(PAC, Swan-Ganz catheter).(PAC, Swan-Ganz catheter).
Hemodynamic ParametersHemodynamic Parameters
CVP & PCWP CO SVR
Cardiogenic High Low High
Extra-cardiac
obstructive (Low) Low High
Hypovolemic Low Low High
Sepsis Variable Variable Low
Toxic Shock (Low) (High) Low
Anaphylaxis Low High Low
Management of hypovoloemic shockManagement of hypovoloemic shock
 Irrespective of etiology the first treatment ofIrrespective of etiology the first treatment of
shock is 100%Oshock is 100%O22 inhalation.inhalation.
 Initial resuscitation requires rapid re-expansionInitial resuscitation requires rapid re-expansion
of the circulating intravascular volume andof the circulating intravascular volume and
interventions to control ongoing losses.interventions to control ongoing losses.
 Volume resuscitation is initiated with the rapidVolume resuscitation is initiated with the rapid
infusion of a balanced salt solution such asinfusion of a balanced salt solution such as
Ringer's lactate or Normal saline through large-Ringer's lactate or Normal saline through large-
bore intravenous lines.bore intravenous lines.
 No distinct benefit from the use of colloid hasNo distinct benefit from the use of colloid has
been demonstrated & in some studies theybeen demonstrated & in some studies they
seem to be even harmful.seem to be even harmful.
Hypovolemic Shock - Fluid SelectionHypovolemic Shock - Fluid Selection
Distribution % Intravascular
Normal saline Extracellular space 25-30%
Lactated Ringer’s Extracellular space 25-30%
5% DA Total body water space 8-10%
Blood/ Colloids Intravascular space 100%
Distribution of fluidDistribution of fluid
Aims of therapyAims of therapy
To achieve and maintainTo achieve and maintain
MAP of 70-80 mm of HgMAP of 70-80 mm of Hg
Urine output >0.5 ml/kg/hourUrine output >0.5 ml/kg/hour
Treatment of the cause.Treatment of the cause.
Further managementFurther management
 Continuing blood loss, with hemoglobinContinuing blood loss, with hemoglobin
concentrations declining to 10 g/dL shouldconcentrations declining to 10 g/dL should
initiate blood transfusion, cross-matched wholeinitiate blood transfusion, cross-matched whole
blood.blood.
 In the presence of severe and/or prolongedIn the presence of severe and/or prolonged
hypotension, inotropic support with dopamine,hypotension, inotropic support with dopamine,
vasopressin, or dobutaminevasopressin, or dobutamine may bemay be required torequired to
maintain adequate ventricular performancemaintain adequate ventricular performance
afterafter blood volume has been restored.blood volume has been restored.
 Once hemorrhage is controlled and the patientOnce hemorrhage is controlled and the patient
has been stabilized, blood transfusions may nothas been stabilized, blood transfusions may not
be continued unless the hemoglobin is <~7g/dLbe continued unless the hemoglobin is <~7g/dL
Cardiogenic shockCardiogenic shock
Myocardial ischemia or infarction (pumpMyocardial ischemia or infarction (pump
failure)failure)
Myocarditis, cardiomyopathyMyocarditis, cardiomyopathy
ArrhythmiaArrhythmia
Acute valvular dysfunctionAcute valvular dysfunction
Cardiogenic Shock
Hemodynamic ParametersHemodynamic Parameters
CVP & PCWP CO SVR
Cardiogenic High Low High
Extra-cardiac
obstructive (Low) Low High
Hypovolemic Low Low High
Sepsis Variable Variable Low
Toxic Shock (Low) (High) Low
Anaphylaxis Low High Low
ManagementManagement
Adjusting volume status to a level thatAdjusting volume status to a level that
ensures optimum LV filling pressure.ensures optimum LV filling pressure.
Use of ionotropic drugs.Use of ionotropic drugs.
Hemodynamic effects ofHemodynamic effects of
adrenoceptor subtypesadrenoceptor subtypes
TypeType TissueTissue ActionsActions
AlphaAlpha Most vascular smoothMost vascular smooth
musclemuscle
ContractionContraction
Beta 1Beta 1 HeartHeart Increases force & rate ofIncreases force & rate of
contractioncontraction
Beta 2Beta 2 Vascular smoothVascular smooth
musclemuscle
RelaxationRelaxation
D 1D 1 Smooth muscleSmooth muscle Dilates renal blood vesselsDilates renal blood vessels
AdrenalineAdrenaline NoradrenalineNoradrenaline DobutamineDobutamine DopamineDopamine
Effects of Inotropic AgentsEffects of Inotropic Agents
EpinephrineEpinephrine α ,βα ,β11 = β= β22 0.02 – 0.50.02 – 0.5
NorepinephrineNorepinephrine αα11, β, β11 >>>> ββ22 0.05 – 0.50.05 – 0.5
DopamineDopamine DD, β, β22, β, β11, α, α 2 -202 -20
DobutamineDobutamine ββ11, β, β22 2 - 202 - 20
Drug Receptor CO SVR Dose Range
(µg/kg/min)
1
DopamineDopamine
An endogenous precursor of norepinephrine withAn endogenous precursor of norepinephrine with
multiple dose-related effectsmultiple dose-related effects
Low Dose (0.5 - 5 mcg/kg/min)Low Dose (0.5 - 5 mcg/kg/min)
ββ22 and dopaminergic (DR) effectsand dopaminergic (DR) effects
Enhanced blood flow to renal and splanchnicEnhanced blood flow to renal and splanchnic
bedsbeds
Moderate Dose (5 -10 mcg/kg/min)Moderate Dose (5 -10 mcg/kg/min)
Positive inotropic effectsPositive inotropic effects
High Dose (>10 mcg/kg/min)High Dose (>10 mcg/kg/min)
αα-actions (vasoconstriction)-actions (vasoconstriction)
Shock
Distributive shockDistributive shock
Septic shockSeptic shock
Anaphylactic shockAnaphylactic shock
Neurogenic shockNeurogenic shock
Vasodilator drugsVasodilator drugs
Acute adrenal insufficiencyAcute adrenal insufficiency
Septic shockSeptic shock
Sepsis with hypotension (arterial blood pressure <90Sepsis with hypotension (arterial blood pressure <90
mmHg systolic, or 40 mmHg less than patient's normalmmHg systolic, or 40 mmHg less than patient's normal
blood pressure) for at least 1 h despite adequate fluidblood pressure) for at least 1 h despite adequate fluid
resuscitation;resuscitation;
oror
Need for vasopressors to maintain systolic bloodNeed for vasopressors to maintain systolic blood
pressure 90 mmHgpressure 90 mmHg oror mean arterial pressure 70 mmHgmean arterial pressure 70 mmHg
Shock
Shock
Features of Septic Shock
High Cardiac OutputHigh Cardiac Output
Low Systemic Vascular ResistanceLow Systemic Vascular Resistance
Myocardial DysfunctionMyocardial Dysfunction
Hypovolemia as Ongoing CirculatingHypovolemia as Ongoing Circulating
Volume Lost To Interstitial SpaceVolume Lost To Interstitial Space
Shock
General managementGeneral management
Measure CVPMeasure CVP If CVP is <8 mm of Hg – fluid is infusedIf CVP is <8 mm of Hg – fluid is infused
to raise it to 8-12 mm of Hgto raise it to 8-12 mm of Hg
Measure MAPMeasure MAP If MAP is still <65 mm of HgIf MAP is still <65 mm of Hg
- use vasoactive agent- use vasoactive agent
Maintain MAP >65 mm of HgMaintain MAP >65 mm of Hg
Management of septic shockManagement of septic shock
Neurogenic ShockNeurogenic Shock
 Neurogenic shock is caused by-Neurogenic shock is caused by-
 traumatic spinal cord injury ortraumatic spinal cord injury or
 effects of an epidural or spinal anesthetic.effects of an epidural or spinal anesthetic.
 This results in loss of sympathetic tone with a reductionThis results in loss of sympathetic tone with a reduction
in systemic vascular resistance and hypotension withoutin systemic vascular resistance and hypotension without
a compensatory tachycardia.a compensatory tachycardia.
 The extremities are often warm, in contrast to the usualThe extremities are often warm, in contrast to the usual
vasoconstriction-induced coolness in hypovolemic orvasoconstriction-induced coolness in hypovolemic or
cardiogenic shock.cardiogenic shock.
 Reflex vagal parasympathetic stimulation evoked byReflex vagal parasympathetic stimulation evoked by
pain, gastric dilation, or fright may simulate neurogenicpain, gastric dilation, or fright may simulate neurogenic
shock, producing hypotension, bradycardia, andshock, producing hypotension, bradycardia, and
syncope.syncope.
Management of neurogenic shockManagement of neurogenic shock
 Treatment involves a simultaneous approach toTreatment involves a simultaneous approach to
the relative hypovolemia and to the loss ofthe relative hypovolemia and to the loss of
vasomotor tone.vasomotor tone.
 Excessive volumes of fluid may be required toExcessive volumes of fluid may be required to
restore normal hemodynamics if given alone.restore normal hemodynamics if given alone.
 A pure alpha-adrenergic agentA pure alpha-adrenergic agent
(Ephedrine/phenylephrine) may be necessary to(Ephedrine/phenylephrine) may be necessary to
augment vascular resistance and maintain anaugment vascular resistance and maintain an
adequate mean arterial pressure.adequate mean arterial pressure.
 In severe cases noradrenaline/adrenaline mayIn severe cases noradrenaline/adrenaline may
be used.be used.
Anaphylactic shockAnaphylactic shock
Anaphylaxis is a potentially life-Anaphylaxis is a potentially life-
threatening, systemic allergic reactionthreatening, systemic allergic reaction
caused by the release of histamine andcaused by the release of histamine and
other vasoactive mediators.other vasoactive mediators.
The most common allergens are foods,The most common allergens are foods,
latex, insect venom and drugs.latex, insect venom and drugs.
Shock
Anaphylaxis: IgE-mediatedAnaphylaxis: IgE-mediated
mast cell degranulationmast cell degranulation
 FoodsFoods
 PeanutsPeanuts
 Tree nutsTree nuts
 Fish and shellfishFish and shellfish
 MilkMilk
 EggsEggs
 Soy productsSoy products
 Insect stingsInsect stings
 Bee venomBee venom
 Wasp venomWasp venom
 Chemicals, drugs and other foreign proteinsChemicals, drugs and other foreign proteins
 Penicillin and other antibioticsPenicillin and other antibiotics
 Intravenous anaesthetic agents, e.g. suxamethonium, propofolIntravenous anaesthetic agents, e.g. suxamethonium, propofol
 LatexLatex
Anaphylactoid, non-IgE-mediatedAnaphylactoid, non-IgE-mediated
mast cell degranulationmast cell degranulation
 DrugsDrugs
 OpiatesOpiates
 AspirinAspirin
 Radiocontrast mediaRadiocontrast media
 PhysicalPhysical
 ExerciseExercise
 ColdCold
 IdiopathicIdiopathic
 No cause can be identified in 30% of patients withNo cause can be identified in 30% of patients with
anaphylaxisanaphylaxis
Management of anaphylaxisManagement of anaphylaxis
 Anaphylaxis is an acute medical emergency. TheAnaphylaxis is an acute medical emergency. The
immediate management includes:immediate management includes:
 preventing further contact with the allergen (e.g. removal of beepreventing further contact with the allergen (e.g. removal of bee
sting)sting)
 ensuring airway patencyensuring airway patency
 administration of oxygenadministration of oxygen
 restoration of blood pressure (laying the patient flat, intravenousrestoration of blood pressure (laying the patient flat, intravenous
fluids)fluids)
 prompt administration of adrenaline (epinephrine).prompt administration of adrenaline (epinephrine).
 Intravenous antihistamines (chlorphenamine 10-20 mg i.m. orIntravenous antihistamines (chlorphenamine 10-20 mg i.m. or
slow i.v. injection), which limit ongoing inflammation.slow i.v. injection), which limit ongoing inflammation.
 Corticosteroids (hydrocortisone 100-300 mg) prevent late-phaseCorticosteroids (hydrocortisone 100-300 mg) prevent late-phase
symptoms in severely affected patients.symptoms in severely affected patients.
Obstructive shockObstructive shock
 Tension pneumothoraxTension pneumothorax
 Pericardial disease (temponade, constrictivePericardial disease (temponade, constrictive
pericarditis)pericarditis)
 Disease of pulmonary vasculature (massiveDisease of pulmonary vasculature (massive
pulmonary emboli, pulmonary hypertension)pulmonary emboli, pulmonary hypertension)
 Cardiac tumor (atrial myxoma)Cardiac tumor (atrial myxoma)
 Left atrial mural thrombusLeft atrial mural thrombus
 Obstuctive valvular disease (aortic or mitralObstuctive valvular disease (aortic or mitral
stenosis)stenosis)
These are medical emergencies requiring prompt diagnosis & treatmentThese are medical emergencies requiring prompt diagnosis & treatment
THANKS TO EVERYBODYTHANKS TO EVERYBODY

More Related Content

PPTX
Hypertensive Crises.pptx
PPTX
Aortic stenosis
PPTX
Anomalous left coronary artery from the pulmonary artery
PPT
Management of Cardiogenic shock
PPTX
Left Ventricular Outflow Tract Obstruction
PPT
Acute limb ischemia
PPTX
Alcohol intoxication & withdrawal
PPT
Airway Management
Hypertensive Crises.pptx
Aortic stenosis
Anomalous left coronary artery from the pulmonary artery
Management of Cardiogenic shock
Left Ventricular Outflow Tract Obstruction
Acute limb ischemia
Alcohol intoxication & withdrawal
Airway Management

What's hot (20)

PPTX
Oropharyngeal Airway.pptx
PPTX
Aortic regurgitation
PPTX
Rheumatic Heart Disease.pptx
PPTX
Pulmonary embolism (PE)
PPTX
Cardiogenic shock
PPTX
Cardiogenic shock
PDF
Pericardiocentesis
PPTX
Electrical injuries
PPTX
Cardiac arrest
PPT
Atrial Fibrillation
PPTX
Defibrillator PPT
PPTX
Cardiac arrest and CPR
PPTX
Septic shock management (1)
PPTX
Aortic stenosis
PPTX
Heart failure
PPTX
Parasternal heave
PPTX
extracorporeal membrane oxygenation (ecmo)
PPTX
Tension Pneumothorax
PDF
Myocardial infarction
Oropharyngeal Airway.pptx
Aortic regurgitation
Rheumatic Heart Disease.pptx
Pulmonary embolism (PE)
Cardiogenic shock
Cardiogenic shock
Pericardiocentesis
Electrical injuries
Cardiac arrest
Atrial Fibrillation
Defibrillator PPT
Cardiac arrest and CPR
Septic shock management (1)
Aortic stenosis
Heart failure
Parasternal heave
extracorporeal membrane oxygenation (ecmo)
Tension Pneumothorax
Myocardial infarction
Ad

Viewers also liked (17)

KEY
FCA 0611 - Shock
PPTX
PPTX
Shock
PDF
Overview of Shock
PDF
Shock
PPTX
Shock
PPT
Shock pathophysiology
PPTX
Effects of shock
PPT
PATHOLOGY AND MANAGEMENT OF SHOCK
PPTX
Shock - Pathophysiology, Clinical Features & Management
PPTX
Pathophysiology of shock
PPT
Disorders of puberty.pptx 2
PPTX
SHOCK
PPSX
A young boy with signs of puberty
PPTX
PPT
Facts of Life - a Talk for Boys on sex education
FCA 0611 - Shock
Shock
Overview of Shock
Shock
Shock
Shock pathophysiology
Effects of shock
PATHOLOGY AND MANAGEMENT OF SHOCK
Shock - Pathophysiology, Clinical Features & Management
Pathophysiology of shock
Disorders of puberty.pptx 2
SHOCK
A young boy with signs of puberty
Facts of Life - a Talk for Boys on sex education
Ad

Similar to Shock (20)

PPT
SHOCK PRESENTATION PPT EASY WAY TO UNDERSTAND
PPT
Essential Hypertension
PPT
Haemorrahge ppt
PPT
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
PPT
Blood vessels pathology
PPT
9 pleural d
PPTX
shock and hemorrhage bt presentation ppt.pptx
PPTX
Cardiogenic shock 1
PPT
Congenital cyanotic Heart Disease -Dr.Wahid Helmi ., Pediatric consultant . ...
PPTX
Shock & Haemorrhage, Blood Transfusion, Blood Products
PPT
12-PLEURAL EFFUSION.pptkkkkkkkkkkkkkkkkkkkkkkkkkkkk
PPT
Recording of arterial blood pressure and Special circulation
PDF
PPTX
Lecture on Haemorrhage
PPT
Ischaemic Heart Disease
PPTX
Hemorrhage & Shock
SHOCK PRESENTATION PPT EASY WAY TO UNDERSTAND
Essential Hypertension
Haemorrahge ppt
Cardiogenicshock by Dr.Afroza Prioty -140123092109-phpapp02
Blood vessels pathology
9 pleural d
shock and hemorrhage bt presentation ppt.pptx
Cardiogenic shock 1
Congenital cyanotic Heart Disease -Dr.Wahid Helmi ., Pediatric consultant . ...
Shock & Haemorrhage, Blood Transfusion, Blood Products
12-PLEURAL EFFUSION.pptkkkkkkkkkkkkkkkkkkkkkkkkkkkk
Recording of arterial blood pressure and Special circulation
Lecture on Haemorrhage
Ischaemic Heart Disease
Hemorrhage & Shock

More from Mashfiqul Hasan (6)

PPTX
Diabetes and Cardiovascular Disease
PPTX
Insulin therapy in the management of diabetes
PPSX
Septicemia
PPT
Arterial blood gas analysis
PPTX
Mitral stenosis in pregnancy
PPTX
My presentation on GOLD
Diabetes and Cardiovascular Disease
Insulin therapy in the management of diabetes
Septicemia
Arterial blood gas analysis
Mitral stenosis in pregnancy
My presentation on GOLD

Recently uploaded (20)

PPTX
Bacteriology and purification of water supply
PPTX
Nutrition needs in a Surgical Patient.pptx
PDF
periodontaldiseasesandtreatments-200626195738.pdf
PPTX
etomidate and ketamine action mechanism.pptx
DOCX
ORGAN SYSTEM DISORDERS Zoology Class Ass
PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PPSX
Man & Medicine power point presentation for the first year MBBS students
PDF
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PPTX
Critical Issues in Periodontal Research- An overview
PPTX
PLANNING in nursing administration study
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
PPTX
INTESTINAL OBSTRUCTION - IDOWU PHILIP O..pptx
PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
PDF
heliotherapy- types and advantages procedure
PPTX
Introduction to CDC (1).pptx for health science students
PPTX
FORENSIC MEDICINE and branches of forensic medicine.pptx
PPTX
Type 2 Diabetes Mellitus (T2DM) Part 3 v2.pptx
PPTX
Genetics and health: study of genes and their roles in inheritance
Bacteriology and purification of water supply
Nutrition needs in a Surgical Patient.pptx
periodontaldiseasesandtreatments-200626195738.pdf
etomidate and ketamine action mechanism.pptx
ORGAN SYSTEM DISORDERS Zoology Class Ass
intrduction to nephrologDDDDDDDDDy lec1.ppt
Man & Medicine power point presentation for the first year MBBS students
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
Critical Issues in Periodontal Research- An overview
PLANNING in nursing administration study
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Communicating with the FDA During an Inspection -August 26, 2025 - GMP.pptx
INTESTINAL OBSTRUCTION - IDOWU PHILIP O..pptx
Cranial nerve palsies (I-XII) - AMBOSS.pdf
heliotherapy- types and advantages procedure
Introduction to CDC (1).pptx for health science students
FORENSIC MEDICINE and branches of forensic medicine.pptx
Type 2 Diabetes Mellitus (T2DM) Part 3 v2.pptx
Genetics and health: study of genes and their roles in inheritance

Shock

  • 1. Presented by: Dr. Mashfiqul HasanPresented by: Dr. Mashfiqul Hasan EmOC (anaesthesia) traineeEmOC (anaesthesia) trainee ICMHICMH
  • 2. Shock is a state of wide spread tissueShock is a state of wide spread tissue hypo perfusion caused byhypo perfusion caused by an inadequate cardiac output oran inadequate cardiac output or ineffective circulatory blood volume,ineffective circulatory blood volume, leading to inadequate supply of oxygenleading to inadequate supply of oxygen and nutrients to the tissues and removal ofand nutrients to the tissues and removal of metabolic wastes from there to the organsmetabolic wastes from there to the organs of excretion.of excretion. What isWhat is shock ?shock ?What isWhat is shock ?shock ?
  • 3. Shock caused by inadequate cardiacShock caused by inadequate cardiac outputoutput CO = SV x HRCO = SV x HR
  • 4. Stroke Volum e Stroke VolumeStroke Volume Volume of Blood pumped by eachVolume of Blood pumped by each ventricle during 1 cardiac cycle.ventricle during 1 cardiac cycle. What affects Stroke volume? Heart Muscle Damag e Blood Volume Mechanica lObstructi on Mechanic al Rhythm Problems
  • 5. Heart rateHeart rate Sever bradycardia due to any cause.Sever bradycardia due to any cause.
  • 6. Shock due to ineffective circulatoryShock due to ineffective circulatory blood volumeblood volume BP = CO x SVRBP = CO x SVR
  • 7. Stages of shockStages of shock Non progressive stageNon progressive stage Progressive stageProgressive stage Irreversible stageIrreversible stage
  • 8. Classification of shockClassification of shock Hypovolemic shockHypovolemic shock Cardiogenic shockCardiogenic shock Distributive shockDistributive shock Obstructive shockObstructive shock
  • 9. Hypovolemic shockHypovolemic shock  Loss of blood:Loss of blood:  External hemorrhage: trauma(accidental, surgical), GIExternal hemorrhage: trauma(accidental, surgical), GI bleeding, PV bleedingbleeding, PV bleeding  Internal hemorrhage: hemothorax, hemoperitoneum,Internal hemorrhage: hemothorax, hemoperitoneum, hematoma, haemorrhage due to pelvic bone fracture,hematoma, haemorrhage due to pelvic bone fracture, femur fracture, etc.femur fracture, etc.  Loss of plasma: burn, exfoliative dermatitisLoss of plasma: burn, exfoliative dermatitis  Loss of fluid & electrolytes:Loss of fluid & electrolytes:  External: diarrhoea, vomiting, excessive sweating,External: diarrhoea, vomiting, excessive sweating, hyperosmolar state (DKA, HONKDC)hyperosmolar state (DKA, HONKDC)  Internal: pancreatitis, ascites, bowel obstructionInternal: pancreatitis, ascites, bowel obstruction
  • 10. Effect of hemorrhage on cardiacEffect of hemorrhage on cardiac output & blood pressureoutput & blood pressure 100%100% 50%50% 00 1010 2020 3030 4040 5050 ArterialArterial pressurepressure Cardiac outputCardiac output Percentage of total blood removedPercentage of total blood removed
  • 11. What prevented fall of bloodWhat prevented fall of blood pressure?pressure?  Reflex sympathetic compensation:Reflex sympathetic compensation:  Arterioles constrict, increasing peripheral resistanceArterioles constrict, increasing peripheral resistance  Vein & venous reservoirs constrict (esp. skin &Vein & venous reservoirs constrict (esp. skin & splanchnic), thereby increasing the venous returnsplanchnic), thereby increasing the venous return  Stimulation of the cardiac activityStimulation of the cardiac activity  Activation of Renin-Angiotensin-AldosteroneActivation of Renin-Angiotensin-Aldosterone systemsystem  Formation and release of vasopressinFormation and release of vasopressin
  • 12. Decreased cardiac outputDecreased cardiac output Decreased arterial pressureDecreased arterial pressure Decreased systemic blood flowDecreased systemic blood flow Decreased nutrition of tissuesDecreased nutrition of tissues Intravascular clottingIntravascular clottingDecreased cardiac nutritionDecreased cardiac nutrition Decreased nutritionDecreased nutrition of vascular systemof vascular system Decreased nutritionDecreased nutrition of the brainof the brain Tissue ischemiaTissue ischemia Decreased vasomotorDecreased vasomotor activityactivity Vascular dilatationVascular dilatation Venous poolingVenous pooling Of bloodOf blood Cardiac depressionCardiac depression Decreased venous returnDecreased venous return IncreasedIncreased CapillaryCapillary permeabilitypermeability DecreasedDecreased blood volumeblood volume Release ofRelease of Toxins/lactic acidosisToxins/lactic acidosis Progression of shockProgression of shock
  • 14. Classification of HaemorrhageClassification of Haemorrhage  Class-I: Blood loss 15%Class-I: Blood loss 15%  Normal pulse rate and blood pressureNormal pulse rate and blood pressure  Tilt test +Tilt test +  Class-II: Blood loss 20-25%Class-II: Blood loss 20-25%  Tachycardia, TachypnoeaTachycardia, Tachypnoea  Low systolic blood pressureLow systolic blood pressure  Pulse pressure less than 30mmHgPulse pressure less than 30mmHg  Delayed capillary fillingDelayed capillary filling  Class-III: Blood loss 30-35%Class-III: Blood loss 30-35%  Skin-cold, clammy and paleSkin-cold, clammy and pale  Severe drop in blood pressureSevere drop in blood pressure  Restlessness, oliguria, metabolic acidosisRestlessness, oliguria, metabolic acidosis  Class-IV Blood loss 40-50%Class-IV Blood loss 40-50%  Profound hypotensionProfound hypotension  Carotid pulse may only be palpableCarotid pulse may only be palpable  Irreversible shockIrreversible shock
  • 15. DiagnosisDiagnosis HistoryHistory Physical signs of haemodynamic instabilityPhysical signs of haemodynamic instability The diagnosis is more difficult when theThe diagnosis is more difficult when the source of blood loss is occult, as into thesource of blood loss is occult, as into the gastrointestinal tract, fracture of femur,gastrointestinal tract, fracture of femur, pelvic fracture or when plasma volumepelvic fracture or when plasma volume alone is depleted.alone is depleted.
  • 16. MonitoringMonitoring  Patients in shock require care in an intensivePatients in shock require care in an intensive care unit.care unit.  Arterial pressure through an indwelling line,Arterial pressure through an indwelling line, pulse, and respiratory rate should be monitoredpulse, and respiratory rate should be monitored continuously;continuously;  A Foley catheter should be inserted to followA Foley catheter should be inserted to follow urine flow;urine flow;  Mental status should be assessed frequently.Mental status should be assessed frequently.  Invasive monitoring: Pulmonary artery catheterInvasive monitoring: Pulmonary artery catheter (PAC, Swan-Ganz catheter).(PAC, Swan-Ganz catheter).
  • 17. Hemodynamic ParametersHemodynamic Parameters CVP & PCWP CO SVR Cardiogenic High Low High Extra-cardiac obstructive (Low) Low High Hypovolemic Low Low High Sepsis Variable Variable Low Toxic Shock (Low) (High) Low Anaphylaxis Low High Low
  • 18. Management of hypovoloemic shockManagement of hypovoloemic shock  Irrespective of etiology the first treatment ofIrrespective of etiology the first treatment of shock is 100%Oshock is 100%O22 inhalation.inhalation.  Initial resuscitation requires rapid re-expansionInitial resuscitation requires rapid re-expansion of the circulating intravascular volume andof the circulating intravascular volume and interventions to control ongoing losses.interventions to control ongoing losses.  Volume resuscitation is initiated with the rapidVolume resuscitation is initiated with the rapid infusion of a balanced salt solution such asinfusion of a balanced salt solution such as Ringer's lactate or Normal saline through large-Ringer's lactate or Normal saline through large- bore intravenous lines.bore intravenous lines.  No distinct benefit from the use of colloid hasNo distinct benefit from the use of colloid has been demonstrated & in some studies theybeen demonstrated & in some studies they seem to be even harmful.seem to be even harmful.
  • 19. Hypovolemic Shock - Fluid SelectionHypovolemic Shock - Fluid Selection Distribution % Intravascular Normal saline Extracellular space 25-30% Lactated Ringer’s Extracellular space 25-30% 5% DA Total body water space 8-10% Blood/ Colloids Intravascular space 100%
  • 21. Aims of therapyAims of therapy To achieve and maintainTo achieve and maintain MAP of 70-80 mm of HgMAP of 70-80 mm of Hg Urine output >0.5 ml/kg/hourUrine output >0.5 ml/kg/hour Treatment of the cause.Treatment of the cause.
  • 22. Further managementFurther management  Continuing blood loss, with hemoglobinContinuing blood loss, with hemoglobin concentrations declining to 10 g/dL shouldconcentrations declining to 10 g/dL should initiate blood transfusion, cross-matched wholeinitiate blood transfusion, cross-matched whole blood.blood.  In the presence of severe and/or prolongedIn the presence of severe and/or prolonged hypotension, inotropic support with dopamine,hypotension, inotropic support with dopamine, vasopressin, or dobutaminevasopressin, or dobutamine may bemay be required torequired to maintain adequate ventricular performancemaintain adequate ventricular performance afterafter blood volume has been restored.blood volume has been restored.  Once hemorrhage is controlled and the patientOnce hemorrhage is controlled and the patient has been stabilized, blood transfusions may nothas been stabilized, blood transfusions may not be continued unless the hemoglobin is <~7g/dLbe continued unless the hemoglobin is <~7g/dL
  • 23. Cardiogenic shockCardiogenic shock Myocardial ischemia or infarction (pumpMyocardial ischemia or infarction (pump failure)failure) Myocarditis, cardiomyopathyMyocarditis, cardiomyopathy ArrhythmiaArrhythmia Acute valvular dysfunctionAcute valvular dysfunction
  • 25. Hemodynamic ParametersHemodynamic Parameters CVP & PCWP CO SVR Cardiogenic High Low High Extra-cardiac obstructive (Low) Low High Hypovolemic Low Low High Sepsis Variable Variable Low Toxic Shock (Low) (High) Low Anaphylaxis Low High Low
  • 26. ManagementManagement Adjusting volume status to a level thatAdjusting volume status to a level that ensures optimum LV filling pressure.ensures optimum LV filling pressure. Use of ionotropic drugs.Use of ionotropic drugs.
  • 27. Hemodynamic effects ofHemodynamic effects of adrenoceptor subtypesadrenoceptor subtypes TypeType TissueTissue ActionsActions AlphaAlpha Most vascular smoothMost vascular smooth musclemuscle ContractionContraction Beta 1Beta 1 HeartHeart Increases force & rate ofIncreases force & rate of contractioncontraction Beta 2Beta 2 Vascular smoothVascular smooth musclemuscle RelaxationRelaxation D 1D 1 Smooth muscleSmooth muscle Dilates renal blood vesselsDilates renal blood vessels AdrenalineAdrenaline NoradrenalineNoradrenaline DobutamineDobutamine DopamineDopamine
  • 28. Effects of Inotropic AgentsEffects of Inotropic Agents EpinephrineEpinephrine α ,βα ,β11 = β= β22 0.02 – 0.50.02 – 0.5 NorepinephrineNorepinephrine αα11, β, β11 >>>> ββ22 0.05 – 0.50.05 – 0.5 DopamineDopamine DD, β, β22, β, β11, α, α 2 -202 -20 DobutamineDobutamine ββ11, β, β22 2 - 202 - 20 Drug Receptor CO SVR Dose Range (µg/kg/min) 1
  • 29. DopamineDopamine An endogenous precursor of norepinephrine withAn endogenous precursor of norepinephrine with multiple dose-related effectsmultiple dose-related effects Low Dose (0.5 - 5 mcg/kg/min)Low Dose (0.5 - 5 mcg/kg/min) ββ22 and dopaminergic (DR) effectsand dopaminergic (DR) effects Enhanced blood flow to renal and splanchnicEnhanced blood flow to renal and splanchnic bedsbeds Moderate Dose (5 -10 mcg/kg/min)Moderate Dose (5 -10 mcg/kg/min) Positive inotropic effectsPositive inotropic effects High Dose (>10 mcg/kg/min)High Dose (>10 mcg/kg/min) αα-actions (vasoconstriction)-actions (vasoconstriction)
  • 31. Distributive shockDistributive shock Septic shockSeptic shock Anaphylactic shockAnaphylactic shock Neurogenic shockNeurogenic shock Vasodilator drugsVasodilator drugs Acute adrenal insufficiencyAcute adrenal insufficiency
  • 32. Septic shockSeptic shock Sepsis with hypotension (arterial blood pressure <90Sepsis with hypotension (arterial blood pressure <90 mmHg systolic, or 40 mmHg less than patient's normalmmHg systolic, or 40 mmHg less than patient's normal blood pressure) for at least 1 h despite adequate fluidblood pressure) for at least 1 h despite adequate fluid resuscitation;resuscitation; oror Need for vasopressors to maintain systolic bloodNeed for vasopressors to maintain systolic blood pressure 90 mmHgpressure 90 mmHg oror mean arterial pressure 70 mmHgmean arterial pressure 70 mmHg
  • 35. Features of Septic Shock High Cardiac OutputHigh Cardiac Output Low Systemic Vascular ResistanceLow Systemic Vascular Resistance Myocardial DysfunctionMyocardial Dysfunction Hypovolemia as Ongoing CirculatingHypovolemia as Ongoing Circulating Volume Lost To Interstitial SpaceVolume Lost To Interstitial Space
  • 37. General managementGeneral management Measure CVPMeasure CVP If CVP is <8 mm of Hg – fluid is infusedIf CVP is <8 mm of Hg – fluid is infused to raise it to 8-12 mm of Hgto raise it to 8-12 mm of Hg Measure MAPMeasure MAP If MAP is still <65 mm of HgIf MAP is still <65 mm of Hg - use vasoactive agent- use vasoactive agent Maintain MAP >65 mm of HgMaintain MAP >65 mm of Hg Management of septic shockManagement of septic shock
  • 38. Neurogenic ShockNeurogenic Shock  Neurogenic shock is caused by-Neurogenic shock is caused by-  traumatic spinal cord injury ortraumatic spinal cord injury or  effects of an epidural or spinal anesthetic.effects of an epidural or spinal anesthetic.  This results in loss of sympathetic tone with a reductionThis results in loss of sympathetic tone with a reduction in systemic vascular resistance and hypotension withoutin systemic vascular resistance and hypotension without a compensatory tachycardia.a compensatory tachycardia.  The extremities are often warm, in contrast to the usualThe extremities are often warm, in contrast to the usual vasoconstriction-induced coolness in hypovolemic orvasoconstriction-induced coolness in hypovolemic or cardiogenic shock.cardiogenic shock.  Reflex vagal parasympathetic stimulation evoked byReflex vagal parasympathetic stimulation evoked by pain, gastric dilation, or fright may simulate neurogenicpain, gastric dilation, or fright may simulate neurogenic shock, producing hypotension, bradycardia, andshock, producing hypotension, bradycardia, and syncope.syncope.
  • 39. Management of neurogenic shockManagement of neurogenic shock  Treatment involves a simultaneous approach toTreatment involves a simultaneous approach to the relative hypovolemia and to the loss ofthe relative hypovolemia and to the loss of vasomotor tone.vasomotor tone.  Excessive volumes of fluid may be required toExcessive volumes of fluid may be required to restore normal hemodynamics if given alone.restore normal hemodynamics if given alone.  A pure alpha-adrenergic agentA pure alpha-adrenergic agent (Ephedrine/phenylephrine) may be necessary to(Ephedrine/phenylephrine) may be necessary to augment vascular resistance and maintain anaugment vascular resistance and maintain an adequate mean arterial pressure.adequate mean arterial pressure.  In severe cases noradrenaline/adrenaline mayIn severe cases noradrenaline/adrenaline may be used.be used.
  • 40. Anaphylactic shockAnaphylactic shock Anaphylaxis is a potentially life-Anaphylaxis is a potentially life- threatening, systemic allergic reactionthreatening, systemic allergic reaction caused by the release of histamine andcaused by the release of histamine and other vasoactive mediators.other vasoactive mediators. The most common allergens are foods,The most common allergens are foods, latex, insect venom and drugs.latex, insect venom and drugs.
  • 42. Anaphylaxis: IgE-mediatedAnaphylaxis: IgE-mediated mast cell degranulationmast cell degranulation  FoodsFoods  PeanutsPeanuts  Tree nutsTree nuts  Fish and shellfishFish and shellfish  MilkMilk  EggsEggs  Soy productsSoy products  Insect stingsInsect stings  Bee venomBee venom  Wasp venomWasp venom  Chemicals, drugs and other foreign proteinsChemicals, drugs and other foreign proteins  Penicillin and other antibioticsPenicillin and other antibiotics  Intravenous anaesthetic agents, e.g. suxamethonium, propofolIntravenous anaesthetic agents, e.g. suxamethonium, propofol  LatexLatex
  • 43. Anaphylactoid, non-IgE-mediatedAnaphylactoid, non-IgE-mediated mast cell degranulationmast cell degranulation  DrugsDrugs  OpiatesOpiates  AspirinAspirin  Radiocontrast mediaRadiocontrast media  PhysicalPhysical  ExerciseExercise  ColdCold  IdiopathicIdiopathic  No cause can be identified in 30% of patients withNo cause can be identified in 30% of patients with anaphylaxisanaphylaxis
  • 44. Management of anaphylaxisManagement of anaphylaxis  Anaphylaxis is an acute medical emergency. TheAnaphylaxis is an acute medical emergency. The immediate management includes:immediate management includes:  preventing further contact with the allergen (e.g. removal of beepreventing further contact with the allergen (e.g. removal of bee sting)sting)  ensuring airway patencyensuring airway patency  administration of oxygenadministration of oxygen  restoration of blood pressure (laying the patient flat, intravenousrestoration of blood pressure (laying the patient flat, intravenous fluids)fluids)  prompt administration of adrenaline (epinephrine).prompt administration of adrenaline (epinephrine).  Intravenous antihistamines (chlorphenamine 10-20 mg i.m. orIntravenous antihistamines (chlorphenamine 10-20 mg i.m. or slow i.v. injection), which limit ongoing inflammation.slow i.v. injection), which limit ongoing inflammation.  Corticosteroids (hydrocortisone 100-300 mg) prevent late-phaseCorticosteroids (hydrocortisone 100-300 mg) prevent late-phase symptoms in severely affected patients.symptoms in severely affected patients.
  • 45. Obstructive shockObstructive shock  Tension pneumothoraxTension pneumothorax  Pericardial disease (temponade, constrictivePericardial disease (temponade, constrictive pericarditis)pericarditis)  Disease of pulmonary vasculature (massiveDisease of pulmonary vasculature (massive pulmonary emboli, pulmonary hypertension)pulmonary emboli, pulmonary hypertension)  Cardiac tumor (atrial myxoma)Cardiac tumor (atrial myxoma)  Left atrial mural thrombusLeft atrial mural thrombus  Obstuctive valvular disease (aortic or mitralObstuctive valvular disease (aortic or mitral stenosis)stenosis) These are medical emergencies requiring prompt diagnosis & treatmentThese are medical emergencies requiring prompt diagnosis & treatment